ABBVIE (ABBV, $180.35) was one of top quarterly gainers, jumping +1 to $180.35 per share. A.I.dvisor analyzed 56 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down. A.I.dvisor found 267 similar cases when ABBV's price went up within three months. In out of those 267 cases, ABBV's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for ABBV are